BANK OF MONTREAL /CAN/ - INTELLIPHARMACEUTICS INTL IN ownership

INTELLIPHARMACEUTICS INTL IN's ticker is IPCIF and the CUSIP is 458173309. A total of 11 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of INTELLIPHARMACEUTICS INTL IN
ValueSharesWeighting
Q4 2018$063
-14.9%
0.00%
Q3 2018$0740.00%
Other shareholders
INTELLIPHARMACEUTICS INTL IN shareholders Q3 2018
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 860,000$2,305,0000.14%
BARCLAYS PLC 1,775$5,0000.00%
ROYAL BANK OF CANADA 2,311$6,0000.00%
WELLS FARGO & COMPANY/MN 3$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
TORONTO DOMINION BANK 1,600$4,0000.00%
DEUTSCHE BANK AG\ 1$00.00%
MORGAN STANLEY 2,280$6,0000.00%
BANK OF MONTREAL /CAN/ 74$00.00%
Financial Architects, Inc 200$1,0000.00%
View complete list of INTELLIPHARMACEUTICS INTL IN shareholders